Table 3 of Pelikan, Mol Vis 2013; 19:1453-1470.
Factors | Before the challenge | After the challenge (min) | ||||||
---|---|---|---|---|---|---|---|---|
0–10 | 20–30 | 60 | 90 | 120 | 180 | 240 | ||
Histamine ng/ml | ||||||||
- SICR | <1.0 | 3.5±0.9* | 5.1±1.3* | 1.2±0.4 | <1.0 | <1.0 | <1.0 | <1.0 |
- PBS | <1.0 | <1.0 | 1.2±0.1 | <1.0 | <1.0 | <1.0 | <1.0 | <1.0 |
Tryptase µg/l | ||||||||
- SICR | <1.0 | <1.0 | 2.7±0.4* | 1.9±0.6* | <1.0 | <1.0 | <1.0 | <1.0 |
- PBS | <1.0 | <1.0 | <1.0 | <1.0 | <1.0 | <1.0 | <1.0 | <1.0 |
ECP µg/l | ||||||||
- SICR | 2.3±0.1 | <2.0 | 6.8±1.3* | 7.2±0.8* | 4.5±0.7* | <2.0 | <2.0 | <2.0 |
- PBS | 2.1±0.1 | <2.0 | <2.0 | <2.0 | 2.1±0.1 | <2.0 | <2.0 | <2.0 |
LTC4 pg/ml | ||||||||
- SICR | 2.3±0.1 | <2.1 | 6.7±0.9* | 6.3±1.0* | 5.2±0.8* | 2.6±0.3 | <2.1 | <2.1 |
- PBS | 2.2±0.1 | <2.1 | <2.1 | <2.1 | 2.3±0.2 | <2.1 | <2.1 | <2.1 |
IL-4 pg/ml | ||||||||
- SICR | 0.9±0.2 | 1.3±0.5 | 1.1±0.4 | 4.0±0.5* | 7.7±1.2* | 10.5±2.1* | 8.4±0.6* | <0.7 |
- PBS | 1.3±0.4 | <0.7 | <0.7 | 1.4±0.3 | <0.7 | <0.7 | <0.7 | <0.7 |
IL-5 pg/ml | ||||||||
- SICR | <3.2 | <3.2 | 3.8±0.5 | 3.3±0.1 | 3.4±0.2 | <3.2 | <3.2 | <3.2 |
- PBS | <3.2 | <3.2 | <3.2 | <3.2 | <3.2 | <3.2 | <3.2 | <3.2 |